We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman BI-6015
List Price
$192.00
Your Price
$192.00
Cayman BI-6015 - CAYM (Additional S&H Or Hazmat Fees May Apply)
NETA PART:
CAYM-12032-25
MFG.PART:
12032-25
UNSPSC:
12352200
Manufacturer:
Cayman
Product Description
Gemcitabine monophosphate is a monophosphate form of the deoxycytidine analog gemcitabine (Item No. ). It has synergistic effects when used in nanoparticle form in combination with cisplatin nanoparticles in vitro at a one-to-one molar ratio (IC50s = 5.95 and 34.8 for the nanoparticle combination and gemcitabine monophosphate alone, respectively). In a stroma-rich mouse xenograft model, the nanoparticle combination of gemcitabine and cisplatin inhibits tumor growth and increases apoptosis.
WARNING This product is not for human or veterinary use.
Technical Information
Formal Name
2′-deoxy-2′,2′-
CAS Number
116371-67-6
Molecular Formula
C9H12F2N3O7P
Formula Weight
343.2
Purity
≥95%
Formulation
A crystalline solid
Solubility
- DMF: 10 mg/ml
- DMSO: 10 mg/ml
- PBS (pH 7.2): 10 mg/ml
λmax
271 nm
SMILES
[H][C@]1(N2C(N=C(N)C=C2)=O)C(F)(F)[C@H](O)[C@@H](COP(O)(O)=O)O1
InChi Code
InChI=1S/C9H12F2N3O7P/c10-9(11)6(15)4(3-20-22(17,18)19)21-7(9)14-2-1-5(12)13-8(14)16/h1-2,4,6-7,15H,3H2,(H2,12,13,16)(H2,17,18,19)/t4-,6-,7-/m1/s1
InChi Key
KNTREFQOVSMROS-QPPQHZFASA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Stability
≥ 4 years
| SKU | CAYM-12032-25 |
|---|---|
| Featured | No |
| Supplier Part Number | 12032-25 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Refrigerated |
| CountryOfOrigin | United States |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 2 |
| Hazardous | N |
| CAS Number | 93987-29-2 |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |